Telemonitoring of Pregnancies Complicated With Gestational Diabetes Mellitus.
NCT06251466
Summary
This interventional study examines the addition of telemonitoring (TM) in prenatal care for gestational diabetes mellitus (GDM). By incorporating TM into the prenatal care for GDM, it is expected to achieve faster and improved follow-up, resulting in faster reaction time in the detection of aberrant blood glucose levels. Therefore, the overarching aim is to improve maternal and newborn pregnancy outcomes through optimized monitoring strategies (TM).
Eligibility
Inclusion Criteria: * Diagnosis of gestational diabetes mellitus * Minimum 20 weeks of pregnancy * Is proficient in Dutch * Signing the Informed Consent Exclusion Criteria: * \<20 weeks of pregnancy * Diagnosis of type 1 diabetes * Congenital anomalies identified in the fetus * Participant does not own a smartphone
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06251466